NCT02812849撤回不适用
Somatostatin Receptor Imaging in Cardiac Sarcoidosis
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Sensitivity to detect cardiac sarcoidosis
研究概览
简要总结
The purpose of the trial is to determine the accuracy of Cu-64 labelled DOTATATE for diagnosing cardiac sarcoidosis using PET/CT or PET/MRI.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Group A: Suspected cardiac sarcoidosis Group B: Known cardiac sarcoidosis, clinical follow-up Group C: Myocarditis or dilated cardiomyopathy (Non-cardiac sarcoidosis)
排除标准
- •Infection Pregnancy Severe claustrophobia Weight >140 kg
研究组 & 干预措施
Suspected cardiac sarcoidosis
Cu-64 DOTATATE PET/CT or PET/MRI
干预措施: Cu-64 DOTATATE (Drug)
Known cardiac sarcoidosis
Cu-64 DOTATATE PET/CT or PET/MRI
干预措施: Cu-64 DOTATATE (Drug)
Other inflammatory cardiac disease
Cu-64 DOTATATE PET/CT or PET/MRI
干预措施: Cu-64 DOTATATE (Drug)
结局指标
主要结局
Sensitivity to detect cardiac sarcoidosis
时间窗: 1 day at PET/CT examination
Specificity to detect cardiac sarcoidosis
时间窗: 1 day at PET/CT examination
次要结局
未报告次要终点
研究者
Rasmus S. Ripa
MD, DMSc
Rigshospitalet, Denmark
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Somatostatin Receptor Imaging in Patients With Suspected Cardiac SarcoidosisSarcoidosisNCT02546388Marcelo F. Di Carli, MD, FACC17
招募中
2 期
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive TumorsNeuroendocrine TumorsNCT04888481University of Alberta600
已完成
不适用
PET Imaging in Patients With Suspected Cardiac SarcoidosisCardiac SarcoidosisNCT03746847University of Pennsylvania20
Unknown
2 期
Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective EndocarditisInfective EndocarditisNCT05183555Central Hospital, Nancy, France14
已完成
4 期
d68Ga-DOTATATE PET/CT Assessment of Cardiac SarcoidosisCardiac SarcoidosisNCT03549598Mayo Clinic15